L.E. DeLanney

1.7k total citations
27 papers, 1.4k citations indexed

About

L.E. DeLanney is a scholar working on Cellular and Molecular Neuroscience, Neurology and Organic Chemistry. According to data from OpenAlex, L.E. DeLanney has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 13 papers in Neurology and 4 papers in Organic Chemistry. Recurrent topics in L.E. DeLanney's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). L.E. DeLanney is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). L.E. DeLanney collaborates with scholars based in United States, Sweden and Switzerland. L.E. DeLanney's co-authors include Ian Irwin, J. William Langston, G.A. Ricaurte, J. William Langston, Lysia S. Forno, Stephen J. Peroutka, George A. Ricaurte, Bruce Quinn, Rosario Moratalla and Ann M. Graybiel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, NeuroImage and Brain Research.

In The Last Decade

L.E. DeLanney

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.E. DeLanney United States 17 971 768 237 181 172 27 1.4k
Noelia Granado Spain 18 1.0k 1.1× 443 0.6× 230 1.0× 441 2.4× 111 0.6× 28 1.7k
Sara Ares‐Santos Spain 11 641 0.7× 282 0.4× 102 0.4× 220 1.2× 40 0.2× 11 886
Trent J. Volz United States 17 833 0.9× 143 0.2× 151 0.6× 441 2.4× 87 0.5× 21 1.2k
Rodolfo Silveira Uruguay 15 479 0.5× 189 0.2× 39 0.2× 177 1.0× 48 0.3× 26 779
Eva de Lago Spain 27 907 0.9× 343 0.4× 93 0.4× 248 1.4× 27 0.2× 47 1.8k
Li‐Jan Chang Canada 12 474 0.5× 260 0.3× 28 0.1× 495 2.7× 23 0.1× 14 1.2k
Lance A. Smith United Kingdom 26 1.1k 1.2× 1.2k 1.6× 19 0.1× 381 2.1× 23 0.1× 38 1.9k
Sally J. Boyson United States 13 820 0.8× 685 0.9× 22 0.1× 833 4.6× 17 0.1× 13 1.5k
Kristen A. Stout United States 17 602 0.6× 434 0.6× 23 0.1× 459 2.5× 19 0.1× 23 1.2k
Steven M. Graves United States 17 739 0.8× 406 0.5× 16 0.1× 323 1.8× 29 0.2× 31 1.1k

Countries citing papers authored by L.E. DeLanney

Since Specialization
Citations

This map shows the geographic impact of L.E. DeLanney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.E. DeLanney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.E. DeLanney more than expected).

Fields of papers citing papers by L.E. DeLanney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.E. DeLanney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.E. DeLanney. The network helps show where L.E. DeLanney may publish in the future.

Co-authorship network of co-authors of L.E. DeLanney

This figure shows the co-authorship network connecting the top 25 collaborators of L.E. DeLanney. A scholar is included among the top collaborators of L.E. DeLanney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.E. DeLanney. L.E. DeLanney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeLanney, L.E.. (2015). Lymphosarcoma in the Mexican Axolotl, Ambystoma mexicanum. Proceedings of the International Symposium on Comparative Leukemia Research. 642–642.
2.
Yee, Randa E., Ian Irwin, D. B. Stout, et al.. (2001). Novel observations with FDOPA‐PET imaging after early nigrostriatal damage. Movement Disorders. 16(5). 838–848. 32 indexed citations
3.
Yee, Randa E., Shan Huang, D. B. Stout, et al.. (2000). Nigrostriatal Reduction of Aromatic L‐Amino Acid Decarboxylase Activity in MPTP‐Treated Squirrel Monkeys: In Vivo and In Vitro Investigations. Journal of Neurochemistry. 74(3). 1147–1157. 19 indexed citations
4.
Irwin, Ian, L.E. DeLanney, Piu Chan, et al.. (1997). Nigrostriatal Monoamine Oxidase A and B in Aging Squirrel Monkeys and C57BL/6 Mice. Neurobiology of Aging. 18(2). 235–241. 17 indexed citations
5.
Forno, Lysia S., L.E. DeLanney, Ian Irwin, & J. William Langston. (1996). Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey.. PubMed. 69. 217–28. 43 indexed citations
6.
Forno, Lysia S., L.E. DeLanney, Ian Irwin, & J. William Langston. (1993). Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations.. PubMed. 60. 600–8. 154 indexed citations
7.
Graybiel, Ann M., Rosario Moratalla, Bruce Quinn, et al.. (1993). Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.. PubMed. 60. 34–9. 15 indexed citations
8.
Moratalla, Rosario, Bruce Quinn, L.E. DeLanney, et al.. (1992). Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.. Proceedings of the National Academy of Sciences. 89(9). 3859–3863. 114 indexed citations
9.
Monte, Donato A. Di, Ellen Y. Wu, Ian Irwin, L.E. DeLanney, & J. William Langston. (1991). Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.. Journal of Pharmacology and Experimental Therapeutics. 258(2). 594–600. 39 indexed citations
10.
Ricaurte, G.A., L.E. DeLanney, Ian Irwin, et al.. (1989). Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine. Brain Research. 490(2). 301–306. 15 indexed citations
11.
Ricaurte, G.A., L.E. DeLanney, Sandra G. Wiener, Ian Irwin, & J. William Langston. (1988). 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Brain Research. 474(2). 359–363. 73 indexed citations
12.
Ricaurte, G.A., L.E. DeLanney, Kevin T. Finnegan, Ian Irwin, & J. William Langston. (1988). The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging. Brain Research. 438(1-2). 395–398. 10 indexed citations
13.
Ricaurte, G.A., L.E. DeLanney, Ian Irwin, & J. William Langston. (1988). Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Research. 446(1). 165–168. 184 indexed citations
14.
Finnegan, Kevin T., Ian Irwin, L.E. DeLanney, G.A. Ricaurte, & J. William Langston. (1987). 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 1144–1151. 18 indexed citations
15.
Ricaurte, G.A., et al.. (1987). 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain. European Journal of Pharmacology. 137(2-3). 265–268. 41 indexed citations
16.
Ricaurte, G.A., et al.. (1987). Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Research. 403(1). 43–51. 158 indexed citations
17.
Ricaurte, George A., J. William Langston, L.E. DeLanney, et al.. (1986). Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment. Brain Research. 376(1). 117–124. 152 indexed citations
18.
Forno, Lysia S., et al.. (1986). ULTRASTRUCTURE OF NERVE CELL DEGENERATION IN THE SUBSTANTIA NIGRA IN EXPERIMENTAL MPTP-INDUCED PARKINSONISM IN THE MOUSE AND IN THE SQUIRREL MONKEY. Journal of Neuropathology & Experimental Neurology. 45(3). 376–376. 3 indexed citations
19.
Peroutka, Stephen J., et al.. (1985). 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.. PubMed. 48(2). 163–71. 15 indexed citations
20.
DeLanney, L.E., et al.. (1967). Actinomycin D: Effect on induced metamorphosis in the Mexican axolotl. Journal of Experimental Zoology. 165(3). 425–431. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noelia Granado Breakdown of academic impact, for papers by Sara Ares‐Santos Breakdown of academic impact, for papers by Trent J. Volz Breakdown of academic impact, for papers by Rodolfo Silveira Breakdown of academic impact, for papers by Eva de Lago Breakdown of academic impact, for papers by Li‐Jan Chang Breakdown of academic impact, for papers by Lance A. Smith Breakdown of academic impact, for papers by Sally J. Boyson Breakdown of academic impact, for papers by Kristen A. Stout Breakdown of academic impact, for papers by Steven M. Graves
Rankless by CCL
2026